ReviewFrontiers in cardiovascular medicine2026
Bibliometric analysis of research hotspots and emerging trends in microRNAs and atherosclerosis (2007-2025).
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: An increasing number of studies have demonstrated that microRNAs (miRNAs) play critical roles in atherosclerosis (AS) and have emerged as promising therapeutic targets in this disease. Through a bibliometric approach, we constructed a comprehensive analytical framework to systematically explore key research topics and emerging trends in this field. Methods: Relevant literature was first retrieved from three core databases, namely the Web of Science Core Collection (WOSCC), Scopus, and PubMed. Duplicate records among the retrieved literature were removed using Python (version 3.11). Subsequent data analysis was performed using RStudio, CiteSpace, VOSviewer, WPS Office, and SciMAgo Graphica. The specific analytical dimensions included the following: co-occurrence analysis to determine the frequency of key elements such as countries, regions, and institutions; keyword clustering analysis; and burst detection analysis to identify research trends and hotspots in this field. Results: A total of 3,478 publications published between 2007 and 2025 were included in the analysis. China and the United States were identified as the most influential countries, contributing the highest number of publications in this field. Christian Weber and Carlos Fernández-Hernando were recognized as leading experts based on their high publication output. Keyword analysis revealed that miRNAs are primarily involved in regulating AS-related processes, including inflammation and immune responses, lipid metabolism, and cellular functions. Future research is expected to increasingly focus on the translational applications of miRNAs in AS. The expression levels of specific circulating miRNAs could serve as biomarkers for the diagnosis of AS or the prediction of disease prognosis. In clinical applications, greater emphasis is expected to be placed on the development of novel materials for the targeted delivery of miRNA-based therapeutics to AS lesions. Discussion: This study employed bibliometric methods to analyze the applications of miRNAs in AS, elucidate research trends and frontiers, and provide guidance for the optimization of therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.